These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5690805)

  • 1. Studies on mescaline XIX: a new theory concernig the nature of schizophrenia.
    Denber HC; Teller DN
    Psychosomatics; 1968; 9(3):145-51. PubMed ID: 5690805
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans.
    Charalampous KD
    Behav Neuropsychiatry; 1971; 2(11):26-9 passim. PubMed ID: 5566331
    [No Abstract]   [Full Text] [Related]  

  • 3. Defining schizophrenia with the techniques of molecular biology.
    Teller DN; Denber HC
    Dis Nerv Syst; 1968 May; 29(5):Suppl:93-112. PubMed ID: 4386264
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chronic treatment with mescaline upon tissue levels of the drug.
    Sethy VH; Winter JC
    Experientia; 1973 May; 29(5):571-2. PubMed ID: 4730293
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on accumulation of (14C)-mescaline in brain homogenates: effects of psychotropic and other agents.
    Shah NS; Gulati OD
    Pharmacology; 1975; 13(4):273-80. PubMed ID: 242020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylation of mescaline in rat brains.
    Ho BT; Pong SF; Browne RG; Walker KE
    Experientia; 1973 Mar; 29(3):275-7. PubMed ID: 4708698
    [No Abstract]   [Full Text] [Related]  

  • 7. The uptake and distribution of 14-C-mescaline in different organs of developing rat.
    Shah NS; Shah KR; Lawrence RS; Neely AE
    Drug Metab Dispos; 1975; 3(2):74-9. PubMed ID: 236161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoradiography studies on the distribution of 3H-mescaline in mammals].
    Lehr E; Korr H; Seiler N; Werner G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):268-9. PubMed ID: 4242414
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of mescaline and 3,4-dimethoxy-phenylethylamine in isolated brain mitochondria and brain homogenate.
    Shah NS; Himwich HE
    Brain Res; 1971 Nov; 34(1):163-70. PubMed ID: 5124914
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the chlorpromazine-induced prolongation of the disappearance of mescaline from mouse tissues.
    Shah NS; Gulati OD
    Toxicol Appl Pharmacol; 1975 Dec; 34(3):441-8. PubMed ID: 1209638
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidative metabolism of mescaline in the central nervous system. IV. In vivo metabolism of mescaline and 2,3,4-trimethoxy-beta-phenylethylamine.
    Seiler N; Demisch L
    Biochem Pharmacol; 1974 Jan; 23(2):273-87. PubMed ID: 4813344
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidative metabolism of mescaline in the central nervous system. 3. Side chain degradation of mescaline and formation of 3,4,5-trimethoxy-benzoic acid in vivo.
    Seiler N; Demisch L
    Biochem Pharmacol; 1974 Jan; 23(2):259-71. PubMed ID: 4813343
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on mescaline XVIII: effect of phenothiazines, amphetamine and amobarbital sodium on uptake into brain and viscera.
    Denber HC; Teller DN
    Agressologie; 1968; 9(1):127-36. PubMed ID: 5681815
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidative metabolism of mescaline in the central nervous system--V. In vitro deamination of mescaline to 3,4,5-trimethoxy-benzoic acid.
    Demisch L; Seiler N
    Biochem Pharmacol; 1975 Mar; 24(5):575-80. PubMed ID: 1125061
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxidative degradation of mescaline in the central nervous system. I. Properties of the mescaline-degrading enzyme].
    Seiler N
    Hoppe Seylers Z Physiol Chem; 1965; 341(1):105-10. PubMed ID: 5896221
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug interaction--effect of chlorpromazine on the disposition of 8- 14 C-mescaline in fetal and maternal brain and liver in pregnant mouse.
    Shah NS; Neely AE
    Biochem Pharmacol; 1973 Jun; 22(12):1535-8. PubMed ID: 4732531
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxidative metabolism of mescaline in the central nervous system. II. Oxidative deamination of mescaline and 2,3,4-trimethoxy-beta-phenylethylamine by different mouse brain area in vitro.
    Seiler N; Demisch L
    Biochem Pharmacol; 1971 Sep; 20(9):2485-93. PubMed ID: 5163157
    [No Abstract]   [Full Text] [Related]  

  • 19. Mescaline and related compounds.
    Patel AR
    Fortschr Arzneimittelforsch; 1968; 11():11-47. PubMed ID: 4873202
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoradiographic studies on the distribution of 3H-2,3,4-trimethoxy-beta-phenylethylamine in the mouse.
    Korr H; Seiler N
    Psychopharmacologia; 1976; 46(1):53-8. PubMed ID: 1257367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.